Skip to main content
. Author manuscript; available in PMC: 2020 Mar 2.
Published in final edited form as: FASEB Bioadv. 2019 Apr 12;1(7):404–414. doi: 10.1096/fba.2018-00075

Table 1–

Slope and intercept values obtained from dose response analysis in MM1.S cells infected with pLKO.1 or ACA11 after treatment with bortezomib or melphalan

Treatment Condition Slope Intercept p value
Cell number bortezomib pLKO.1 −0.13±0.01 12.29 0.008
ACA11 −0.26±0.01 8.29
melphalan pLKO.1 −0.02±0.01 29.27 0.33
ACA11 −0.05±0.01 29.79

Cell proliferation bortezomib pLKO.1 −0.06±0.02 15.10 0.06
ACA11 −0.13±0.01 12.05
melphalan pLKO.1 −0.01±0.004 55.08 0.32
ACA11 −0.04±0.023 33.94